Patents by Inventor Susan Lynn Way

Susan Lynn Way has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination therapy with p38 MAP kinase inhibitors and their pharmaceutical compositions
    Publication number: 20040110755
    Abstract: The present invention relates to pharmaceutical combinations therapies based on p38 kinase inhibitors and another active ingredient, pharmaceutical compositions comprising such combinations, processes for preparing them and their use in the treatment of cytokine mediated diseases.
    Type: Application
    Filed: August 11, 2003
    Publication date: June 10, 2004
    Applicants: Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim France
    Inventors: Stefan Simianer, Pascal Bilbault, Michael L. Cappola, Susan Lynn Way
  • Parenteral formulations of 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-yl]-urea
    Publication number: 20030068340
    Abstract: Disclosed are formulations and compositions comprising, and process for preparing, improved parenteral dosage forms of 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-yl]-urea. Also disclosed are methods of treating cytokine mediated diseases using such formulations and compositions.
    Type: Application
    Filed: October 21, 2002
    Publication date: April 10, 2003
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Michael L. Cappola, Susan Lynn Way